The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1

BACKGROUND: Heat shock protein 90 (HSP90) inhibitors have emerged as a promising class of anti-cancer drugs in both solid and hematologic malignancies. The HSP90 family includes the cytosolic HSP90 (HSP90AA1), the ER paralogue gp96 (HSP90B1) and the mitochondrial member TRAP1 (HSP90L). We evaluated...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Usmani, Saad Z, Bona, Robert D, Chiosis, Gabriela, Li, Zihai
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2010
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974653/
https://ncbi.nlm.nih.gov/pubmed/20977755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-3-40
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia